We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Screening FDA-approved oncology drugs identifies romidepsin as a potential treatment for osteosarcoma, indicating further investigation is needed.
Clinical information for patients and romidepsin ED₅₀s.
No takes yet. Share an insight, caveat, or question.
Seiden et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: